Orchestra BioMed Holdings, Inc.
NASDAQ:OBIOBiotechnology
Healthcare
$7.46 +1.16%
+$0.05 today
- Market cap
- $587.14M
- Beta
- 0.50
- P/E (TTM)
- -2.8
- EPS (TTM)
- -$1.42
52W Low $2.20High $5.42
Volume 1.20M
Average 0.22M
Price history
Orchestra BioMed Holdings, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+60.09%
Period high
$7.46
Period low
$3.49
Latest
$7.46
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13D/A | Nov 12, 2026 | Nov 12, 2026 | |
| 4 | Nov 12, 2026 | Nov 12, 2026 | |
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| 4 | Nov 9, 2026 | Nov 9, 2026 | |
| 4 | Nov 9, 2026 | Nov 9, 2026 | |
| 4 | Nov 9, 2026 | Nov 9, 2026 | |
| 4 | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| 424B5 | Nov 6, 2026 | Nov 6, 2026 | |
| 424B5 | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 8-K | Oct 1, 2026 | Oct 1, 2026 | |
| 4 | Sep 11, 2026 | Sep 11, 2026 | |
| 4 | Sep 8, 2026 | Sep 8, 2026 |
Competitors
Who does Orchestra BioMed Holdings, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about OBIO's filings, answered from its disclosures.
What is the latest OBIO filing?
The latest filing shown is SC 13D/A dated Nov 12, 2026.
How many recent filings does OBIO have?
Intrinsic Alpha currently shows 20 recent filings for OBIO.
Continue the stock analysis
Jump to another research area for this company.